Skip to main content Accessibility help
×
Home

Control of an Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Australia after Introduction of Environmental Cleaning with a Commercial Oxidizing Disinfectant

  • Michelle Doidge (a1), Anthony M. Allworth (a1), Marion Woods (a1), Penelope Marshall (a1), Michael Terry (a1), Kathryn O'Brien (a1), Hwee Mian Goh (a2), Narelle George (a3), Graeme R. Nimmo (a3), Mark A. Schembri (a2), Jeffrey Lipman (a4) and David L. Paterson (a1) (a3) (a5) (a6)...

Abstract

In the midst of an outbreak, carbapenem-resistant Acinetobacter baumannii was grown from samples of multiple environmental sites in an intensive care unit. A commercial oxidizing disinfectant (potassium peroxomonosulphate 50%, sodium alkyl benzene sulphonate 15%, and sulphamic acid 5%) was introduced throughout the intensive care unit, and its use coincided with cessation of the outbreak.

Copyright

Corresponding author

8th Fl, UQCCR Bldg, Royal Brisbane and Women's Hospital, Brisbane 4029, Australia (david.antibiotics@gmail.com)

References

Hide All
1. Depuydt, P, Benoit, D, Vogelaers, D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic-resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008;34:675682.
2. Maragakis, LL, Tucker, MG, Miller, RG, Carroll, KC, Perl, TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008;299:25132514.
3. Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:22332239.
4. Wisplinghoff, H, Schmitt, R, Wohrmann, A, Stefanik, D, Seifert, H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii . J Hosp Infect 2007;66:174181.
5. Kawamura-Sato, K, Wachino, J, Kondo, T, Ito, H, Arakawa, Y. Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J Antimicrob Chemother 2008;61:568576.
6. Rodriguez-Bano, J, Marti, S, Soto, S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008;14:276278.
7. Hernndez, A, Martro, E, Matas, L, Martin, M, Ausina, V. Assessment of in vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines. J Hosp Infect 2000;46:203209.
8. Peleg, AY, Seifert, H, Paterson, DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538582.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed